|
CHRAC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.009800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.429530E-02 |
| Normal-vs-Stage2 |
8.082300E-02 |
| Normal-vs-Stage3 |
7.824000E-01 |
| Normal-vs-Stage4 |
4.028600E-01 |
| Stage1-vs-Stage2 |
8.299600E-01 |
| Stage1-vs-Stage3 |
2.131800E-01 |
| Stage1-vs-Stage4 |
5.238300E-02 |
| Stage2-vs-Stage3 |
2.887600E-01 |
| Stage2-vs-Stage4 |
6.091500E-02 |
| Stage3-vs-Stage4 |
3.679800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.549900E-02 |
| Normal-vs-AfricanAmerican |
2.800600E-03 |
| Normal-vs-Asian |
5.102400E-01 |
| Caucasian-vs-AfricanAmerican |
1.694610E-01 |
| Caucasian-vs-Asian |
8.456000E-01 |
| AfricanAmerican-vs-Asian |
4.535600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339640E-02 |
| Normal-vs-Female |
2.186600E-01 |
| Male-vs-Female |
4.389800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.359900E-02 |
| Normal-vs-Extreme_Weight |
9.950000E-02 |
| Normal-vs-Obese |
2.589200E-01 |
| Normal-vs-Extreme_Obese |
1.998370E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.792200E-01 |
| Normal_Weight-vs-Obese |
5.542200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.453400E-01 |
| Extreme_Weight-vs-Obese |
7.092000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.905190E-01 |
| Obese-vs-Extreme_Obese |
1.346010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.802800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.688000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.201100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.722000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.381840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.182700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.855190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.743770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.488400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.735600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.634800E-01 |
| Normal-VS-Type2 PRCC |
3.26939999995002E-06 |
| Normal-VS-KIRP CIMP |
6.937500E-03 |
| Normal-VS-Unclassified PRCC |
1.707510E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.223030E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.420230E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.230430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.90770005243013E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.809200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.27539999999782E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.302100E-03 |
| Normal-vs-N1 |
2.911800E-01 |
| Normal-vs-N2 |
7.841800E-01 |
| N0-vs-N1 |
5.342500E-03 |
| N0-vs-N2 |
1.903840E-01 |
| N1-vs-N2 |
9.720800E-01 |
|
|
